International Cancer Genome Consortium (ICGC) Canada

Partner Institutions

International Cancer Genome Consortium (ICGC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

• Cancer Research UK (CRUK)
• Carlos Slim Health Institute
• Chinese Cancer Genome Consortium (CCGC)
• Department of Biotechnology (DBT)
• FP7 - Finland, EC
• French National Cancer Institute (INCa)
• Genome Canada
• German Aerospace Center (DLR)
• German Cancer Aid (DKH)
• German Federal Ministry of Education and Research (BMBF)
• Japan Agency for Medical Research and Development (AMED)
• King Faisal Specialist Hospital and Research Centre (KFSH&RC)
• Korea Research Institute of Bioscience and Biotechnology (KRIBB)
• NIH National Cancer Institute (NCI)
• NIH National Human Genome Research Institute (NHGRI)
• National Cancer Center (NCC)
• National Health and Medical Research Council (NHMRC)
• Ontario Institute for Cancer Research (OICR)
• Prostate Cancer Canada (PCC)
• Spain Ministry of Science, Innovation and Universities (MICINN)
• University of Glasgow
• University of Verona (UNIVR)
• Wellcome Sanger Institute
• Wellcome Trust

Affiliated joint institutions and consortia

• ICGC Bone Cancer Project: Osteosarcoma/Chondrosarcoma/Rare Subtypes
• ICGC Breast Cancer Project: Triple Negative/Lobular/Other
• ICGC PedBrainTumor Project
• ICGC Prostate Cancer Project: Adenocarcinoma
• ICGC-MMML-Seq Consortium
• INCa-ICGC Breast Cancer Consortium